Login / Signup

Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply.

W Ray KimLaura E TelepAnand P Chokkalingam
Published in: Alimentary pharmacology & therapeutics (2022)
Keyphrases
  • antiretroviral therapy